Post by
subaru1i on Oct 05, 2023 2:08pm
The Brazil contract is actually around $150 million for LABS
to become profitable in Q1 2024 based on their gross profit margins. That's just for one quarter, so how big then is the total contract minimum on an annualized basis.
Big news on the way folks, hope others are feathering their nest.
Comment by
Starkicker on Oct 05, 2023 2:15pm
I think I liked it better two or three years ago when you used to just say BIG NEWS COMING because then I didn't have to go and fact check your math. These more elaborate speculations are time consuming...lol.
Comment by
subaru1i on Oct 05, 2023 2:18pm
Starkicker, my historical comment still holds true to this day and I have invited Icfa to validate my logic so as not to impinge on your time. But this is not elaborate at all...it is in fact a method used by companies for financial planning and making their cash forecasts for the year.
Comment by
Starkicker on Oct 05, 2023 2:46pm
True, but you don't have all of the information and variables, including if the Brazil partnership is indeed the revenue generator. A lot of quantum leaps and assumptions in your speculation. Don't get me wrong, I hope you're right, but I strongly doubt Mr. Pidduck is intentionally leaving bread crumbs for us.
Comment by
TreborTheGreat on Oct 05, 2023 3:45pm
This is gaslighting. Medpharm does not have a $150MM Brazil contract. This is you swagging "potential" again. Yes, lot of potential. So what?